These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28114441)

  • 1. Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.
    Xia Z; Steele SU; Bakshi A; Clarkson SR; White CC; Schindler MK; Nair G; Dewey BE; Price LR; Ohayon J; Chibnik LB; Cortese IC; De Jager PL; Reich DS
    JAMA Neurol; 2017 Mar; 74(3):293-300. PubMed ID: 28114441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
    Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
    JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and diagnostic features of patients with familial multiple sclerosis.
    Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
    Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
    Abel S; Vavasour I; Lee LE; Johnson P; Ristow S; Ackermans N; Chan J; Cross H; Laule C; Dvorak A; Schabas A; Hernández-Torres E; Tam R; Kuan AJ; Morrow SA; Wilken J; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DKB; Carruthers R; Traboulsee A; Kolind SH
    JAMA Netw Open; 2020 Sep; 3(9):e2014220. PubMed ID: 32990740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.
    De Meo E; Portaccio E; Giorgio A; Ruano L; Goretti B; Niccolai C; Patti F; Chisari CG; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Simone M; Viterbo RG; Bonacchi R; Rocca MA; De Stefano N; Filippi M; Amato MP
    JAMA Neurol; 2021 Apr; 78(4):414-425. PubMed ID: 33393981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease.
    Katsavos S; Artemiadis A; Davaki P; Stamboulis E; Kilindireas K; Anagnostouli M
    Clin Neurol Neurosurg; 2018 Oct; 173():144-149. PubMed ID: 30125837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
    Zivadinov R; Ramasamy DP; Benedict RR; Polak P; Hagemeier J; Magnano C; Dwyer MG; Bergsland N; Bertolino N; Weinstock-Guttman B; Kolb C; Hojnacki D; Utriainen D; Haacke EM; Schweser F
    Radiology; 2016 Dec; 281(3):884-895. PubMed ID: 27308776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies.
    Mortazavi M; Hizarci Ö; Gerdes LA; Havla J; Kümpfel T; Hohlfeld R; Stöcklein S; Keeser D; Ertl-Wagner B
    Neuroimage Clin; 2021; 31():102734. PubMed ID: 34171607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and subclinical neurological involvement in children of conjugal multiple sclerosis patients.
    Constantinescu CS; Grossman RI; Finelli PF; Kamoun M; Zmijewski C; Cohen JA
    Mult Scler; 1995 Nov; 1(3):170-2. PubMed ID: 9345449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images.
    Sparacia G; Agnello F; Gambino A; Sciortino M; Midiri M
    Neuroradiol J; 2018 Aug; 31(4):356-361. PubMed ID: 29565219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.
    Tienari PJ; Salonen O; Wikström J; Valanne L; Palo J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):883-6. PubMed ID: 1431951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.